RNA were generated utilizing reverse transcriptase (RNase H-) for first strand synthesis, Sequenase for second strand synthesis and primers specific for the 5' and 3' termini of the viral genome. These cDNAs were cloned into plasmid pUC18 and infectious RNA transcripts were synthesized in vitro from a bacteriophage T7 RNA polymerase promoter incorporated into the 5' specific primer. The infectivity of transcripts was 16 % that of native PMV RNA. Increasing the poly(A) tail length from A24 to A71 produced a 43 % increase in infectivity. Transcripts synthesized with or without an m7GpppG cap structure were biologically active although uncapped transcripts were much less infectious. The addition of up to 2434 non-viral nucleotides at the 3' end of transcripts decreased but did not abolish infectivity. Insertions of two amino acid residues within the polymerase coding region inactivated viral transcripts. A single amino acid deletion within the capsid protein (CP) produced local lesions of a reduced size as compared to native PMV RNA. Viral particles could not be observed in crude extracts from lesions produced by this deletion mutant suggesting that it exists as a naked RNA species within the host. Mutations to the CP suggest that it is required not only for viral assembly but also for some other unidentified function(s) during the replication cycle.
Introduction
Papaya mosaic virus (PMV) is a flexuous rod-shaped plant virus of the potexvirus group (Koenig & Lesemann, 1978) . The viral genome consists of a single positivesense RNA molecule with a 5' mTGpppG cap structure (AbouHaidar & Bancroft, 1978) and a 3' poly(A) tail (AbouHaidar, 1988) . The genomic organization of the viral RNA is similar to that of other potexviruses, with five open reading frames (ORFs) encoding proteins of M r 176K, 26K, 23K, 12K and 7K (Sit et al., 1989) . The viral RNA acts as an mRNA for the in vitro expression of the 176K protein (Bendena et al., 1985) whereas the 23K capsid protein (CP) is expressed from a 1.0 kb subgenomic RNA (Mackie et al., 1988) . A 2.2kb subgenomic RNA has been detected in PMV-infected tissue but the translational activity of this RNA species remains unknown (Mackie et al., 1988) .
In order to study the functions of the various gene products as well as the interactions between viral proteins and their target RNA sequences, it was necessary to produce a full-length cDNA clone of the genomic RNA. Infectious RNA transcripts could then be synthesized in vitro by use of a bacteriophage RNA polymerase (SP6, T3 or T7) for run-off transcription. Infectious RNA transcripts have been produced from several positivesense RNA plant viruses such as brome mosaic virus (BMV; Ahlquist et al., 1984) , tobacco mosaic virus (TMV; Dawson et al., 1986; Meshi et al., 1986) , cowpea mosaic virus (CPMV; Vos et al., 1988) and tobacco vein mottling virus (TVMV; Domier et al., 1989) . Infectious potexvirus transcripts have also been synthesized for white clover mosaic virus (WC1MV; Beck et al., 1990) , potato virus X (PVX; Hemenway et al., 1990) and clover yellow mosaic virus (CYMV, Holy & AbouHaidar, 1993) . Infectious transcripts have also been generated from cloned defective RNAs of CYMV (White et aI., 1992) .
In this paper, we describe the cloning and generation of infectious RNA transcripts from a full-length cDNA clone of the PMV genome. Mutations were introduced within the polymerase and CP genes of the infectious cDNA clone to determine whether other functions of these proteins, such as host symptom response, could be mapped to regions within these genes.
Methods
Viral RNA extraction. PMV was purified from systemically infected leaves of papaya (Carica papaya L.) essentially by the method of Erickson & Bancroft (1978) . Viral RNA was extracted from purified particles according to the method of AbouHaidar & Bancroft (1978) with Tris-saturated phenol-chloroform (1 : 1 v/v). RNA was precipita- ted with 0.1 M-potassium acetate and 2.5 volumes of 95 % ethanol at -20 °C. The viral RNA was further purified by centrifugation through a 5 to 20 % (w/v) sucrose gradient in 10 mu-Tris HCI pH 7.5, 100 mMNaC1, 1 mM-EDTA at 87800g for 13 h. Fractions corresponding to full-length genomic RNA were collected.
cDNA synthesis and cloning, cDNA synthesis was initiated with synthetic oligonucleotides based on the previously published PMV sequence (Sit et al., 1989) . First strand synthesis was performed with the oligonueleotide 5' CCGGTTAGGTACCT(20) Y, which contains an Asp718 restriction site (underlined), in a 50 gl reaction volume consisting of 10 gg PMV RNA, 25 ng primer, 50 mM-Tri~HC1 pH 8.3, 3 mM-MgC12, 75 mM-KC1, 10 mM-DTT, 0"5 mM-dATP, 0.5 mM-dGTP, 0.5 mM-dCTP, 0.5 mM-dTTP, 50 gg/ml actinomycin D and 2000 units of Superscript RNase H reverse transcriptase (RT; BRL). In order to anneal the primer to the template, the RNA, primer and distilled H20 were combined, incubated at 70 °C for 10 min and cooled slowly to 39 °C. The remaining reagents plus enzyme were then added and incubated at 39 °C for 1.5 h. The reaction was terminated by the addition of EDTA, to a final concentration of 20 mi, and 10 mMTris-HC1 pH 8.0, 1 mM-EDTA (TE) to a final volume of 150 gl. The RNA was then hydrolysed with 0.15 M-NaOH at 65 °C for 1 h and neutralized with 0.15 M-HC1. The cDNA was then precipitated with 2 M-ammonium acetate and 2.5 volumes of 95 % ethanol.
Second strand synthesis was primed with an oligonucleotide (5'
containing a T7 RNA polymerase promoter (underlined) and 5' PMV sequences (in bold). Typically, 10 % of the first strand reaction was combined in a 25 gl reaction volume with 25 ng primer, 1 x Sequenase reaction buffer (40 mM-Tris HC1 pH 7.5, 20 mM-MgC12, 50 mM-NaC1), 6 mM-DTT, 1 mM-dATP, 1 mM-dGTP, 1 mM-dCTP, 1 mM-dTTP and 13 units of Sequenase Version 2.0 (United States Biochemical Corporation). The cDNA, primer, buffer and distilled H~O were combined, incubated at 60 °C for 15 rain and cooled slowly to room temperature. The remaining reagents and enzyme were then added and incubated at room temperature for 5 min and then at 37 °C for an additional 55 min. The reaction was terminated by the addition of EDTA to a final concentration of 20 mM, extracted with phenolchloroform and precipitated with 2 M-ammonium acetate and 2.5 volumes of 95 % ethanol at -20 °C. Double-stranded cDNA was then adapted with dCTP tails and annealed to the dGTP-tailed PstI site of plasmid pUC18 according to the method of AbouHaidar (1988) . Recombinant plasmids were transformed into Escherichia coli DH5e by the CaCI~ method (Maniatis et al., 1982) and selected for on agar plates containing ampicillin and X-Gal. The production of full-length cDNA clones was confirmed by restriction analysis and sequencing of the Y and 3' termini of cDNA inserts from plasmid mini-preparations by the method of Hsiao (1991) . The infectious full-length clone produced was SQ104A3.
Construction of modified clones.
To increase the length of the poly(A) tail at the 3' end of the infectious clone, cDNA inserts were screened for longer poly(A) tails by double digestion of the inserts with restriction enzymes HpaI (position 6078) and AsT718 followed by electrophoresis on a 1% agarose gel. The length of the poly(A) tracts was confirmed by sequencing. A cDNA insert having a poly(A) tail of 71 residues was cleaved with AccI (position 6611)~Asp718 and the resulting DNA fragment eluted from a 1% agarose gel with an Elutrap electroelution apparatus (Schleicher and Schuell) according to the manufacturer's specifications. The DNA fragment was then ligated with T4 DNA ligase into plasmid SQ104A3 which had been cleaved with AccI/AsT718 and dephosphorylated. The resultant clone was designated 71A2. Two separate insertional mutations were introduced into the polymerase gene of clone 71A2 (see Fig. 1 ). The first mutant was constructed by digestion at the unique NcoI site (position 3024), followed by treatment with mnng bean nuclease, to remove the four base overhangs, and ligation of a NotI linker (5' AGCGGCCGCT 3').
This produced clone Nco4B which contained a net addition of two amino acid residues within the conserved carboxy-terminal region of the polymerase gene (Zuidema et al., 1989) . The second mutant, PL6, was constructed at the unique EcoRI site (position 1894) within the non-homologous region of the polymerase gene (see Fig. 1 ). However, the EcoRI site in pUC18 had to be removed by first digesting clone 71A2 with AatlI (position 136 of the PMV sequence) which removed a 638 bp fragment containing one of the two PvuII sites of pUC18, producing clone 71A. This clone was digested with Asp718/PvuII followed by blunting with the large fragment of E. coli DNA polymerase I (Klenow fragment) and ligation to yield clone AE9. The latter was then digested with EcoRI followed by mung bean nuclease to remove the four base overhangs. A NotI linker (as above) was then inserted to produce clone AEN6. The 1946 bp SnaBI/BgllI fragment of AEN6 was then cloned into 71A2, to give mutant PL6.
Mutations to the CP consisted of deletions and insertions clustered at two restriction sites, HpaI (position 6078) and SaclI (position 6433) (see Fig. 1 ). Mutations at the HpaI site involved cleaving the clone 71A2 with HpaI and inserting a NotI linker (see above), giving rise to the mutant CPHN2 which produced premature termination of the CP. Mutant CPHN2 was digested with NotI and treated with mung bean nuclease to produce clone CPN6 containing an insertion of two amino acids in-frame with the CP.
A SphI subclone of the 3' region of PMV (nucleotides 3728 to 6656) was used for the following set of CP mutants. ACP9 was produced by digesting with BstXI (positions 6016, 6222 and 6485) followed by treatment with mung bean nuclease and T4 DNA ligase. This produced a deletion between positions 6019 and 6492 which was still in-frame. The mutated subclone was then placed back into clone 71A2 as a BspDI/AccI fragment (positions 4361 and 6611). Mutants CPX7, CPSN7 and 11CP4 were produced by digestion with SacII, blunting with T4 DNA polymerase and insertion of an XbaI linker (5' CTCTAGAG 3'), a SnaBI linker (5' GTACGTAC 3') or no linker (llCP4), respectively. CPX7 produces premature termination of the CP, CPSN7 adds two amino acids in-frame and 11CP4 causes a shift to the -1 reading frame. Mutant 3CP1 was produced in the same way as 11CP4 but the T4 DNA polymerase reaction produced the deletion of one extra nucleotide at position 6434 resulting in the net loss of one amino acid residue. CPX7, CPSN7, 11CP4 and 3CP1 were subsequently cloned into 71A2 as HpaI/AccI fragments (positions 6078 and 6611).
In vitro transcription. Prior to transcription, DNA templates were linearized with Asp718 (Boehringer Mannheim) or other restriction endonucleases [New England Biolabs (NEB) or BRL] according to the supplier's directions. Transcription reactions were performed essentially as described by Beck et al. (1990) in 100 or 200 lal reaction volumes with T7 RNA polymerase (NEB) in the presence or absence of mTGpppG cap (NEB). RNA transcripts were analysed by electrophoresis on 1% agarose gels to determine RNA concentration and quality.
Infectivity assays. Gomphrena globosa was used as the local lesion host and C. papaya was used as the systemic host. Leaves were lightly dusted with carborundum prior to inoculation which involved rubbing RNA solutions onto leaf surfaces. For local lesion assays, approximately 2 gg of RNA (genomic PMV RNA or in vitro transcripts) in a 25 gl volume were combined with 1 volume of ice-cold inoculation buffer [1% sodium pyrophosphate pH 9.0, 1% bentonite and 1% Celite; Beck et al. (1990) ] and used to inoculate each leaf. Typically, two pairs of leaves were inoculated. In each pair, one leaf served as the test and the other leaf as a control for infectivity by inoculation with genomic PMV RNA (for mutant transcripts, 71A2 transcripts served as the control). Lesion numbers were counted 5 to 7 days post-inoculation. Isolated lesions were ground up with a glass rod in 1.5 ml Eppendorf tubes containing 100 gl of 10 mu-Tris-HCl pH 7.5 and carborundum. After centrifugation for 2 min, 50 gl of the supernatant was used to infect papaya plants or other G. globosa plants to determine the infectivity of progeny virions.
For systemic assays, each of the two uppermost leaves of papaya plants was inoculated with approximately 5 gg of RNA in a 100 gl volume of ice-cold inoculation buffer. Non-inoculated upper leaves were collected 14 to 21 days post-inoculation.
Total RNA extraction. Total RNA was extracted from infected papaya plants according to Palukaitis (1984) . Essentially, 1 to 2 g of leaf tissue was frozen and ground to a powder in liquid nitrogen in a mortar. The powder was solubilized in 3 ml extraction buffer (0.2 MTris-HC1 pH 9"0, 0"4 M-LiCI, 25 mM-EDTA, 1% SDS and 1% diethylpyrocarbonate) and extracted twice with 1 volume of phenoN chloroform (1 : 1 v/v) and once with 1 volume of chloroform. Added to the aqueous phase were 2 volumes of 95 % ethanol and the mixture was incubated at -20 °C overnight. The RNA was pelleted and resuspended in 0.5 ml TE pH 7.5.
Dot blot analysis.
Total RNA from infected papaya leaves was denatured with 10 % formaldehyde-6 x SSC (1 x SSC is 0.15 M-NaC1, 0.015 M-sodium citrate, pH 7-0) at 60 °C for 15 min prior to spotting on nitrocellulose filters. After sample application, the filters were baked at 80 °C in vacuo for 1 h. Filters were incubated in prehybridization buffer (4 x Denhardt's solution, 3 x SSC, 10 mM-EDTA and 250 lag/ml denatured herring sperm DNA) at 65 °C for 4 h followed by addition of random-primed ~2P-labelled probe DNA [prepared according to the method of Feinberg & Vogelstein (1983) ] and incubation at 65 °C for 16 h. Filters were washed twice in 2 x SSC-0.5% SDS at 25 °C for 5 min each, twice in 2 x SSC-0.5 % SDS at 50 °C for 5 min each and twice in 0.1 x SSC~0.5 % SDS at 50 °C for 15 min each. After drying at 25 °C, the filters were exposed to X-ray film.
Results

cDNA cloning
To generate full-length genomic cDNA clones of PMV, two approaches were taken. The first approach involved the ligation of several subclones of PMV presumably generated from independent RNA molecules and used for sequencing the genome (Sit et al., 1989) to produce a single full-length clone. This yielded several full-size clones which proved non-infectious after transcription and inoculation onto local lesion hosts (data not shown). The second method involved synthesis of complete fulllength cDNAs with Superscript RNase H-RT and Sequenase. This RT was chosen because it gave better yields of full-length first strand cDNA than avian myeloblastosis virus RT or unmodified Moloney murine leukaemia virus RT (data not shown). Sequenase Version 2.0 produced a distinct band of the expected size after second strand synthesis, whereas the use of Klenow polymerase produced several shorter bands indicating incomplete second strand synthesis (see Fig. 2 ).
Following cDNA synthesis, several methods were used to clone the cDNA into plasmid pUC18. Initially, the primers had been designed for cloning inserts by the method of Schmid et al. (1987) which involved treatment of the ds cDNA with T4 DNA polymerase in the presence of dATP/dTTP to produce 5' overhangs compatible with XmaI (5' primer) and AccI (3' primer) followed by ligation into pUC18 previously cleaved with XmaI/AccI. However, the use of GC-tailing with terminal deoxynucleotidyl transferase yielded one fulllength clone for every eight white colonies picked, as judged by restriction digests. We were unable to obtain any full-length clones by the method of Schmid et al. (1987) or by straight blunt-end ligation. XbaI linkers were also used for insertion of the c D N A into pUC18 since no XbaI sites were observed in the genomic PMV sequence. However, this approach led to the production of truncated c D N A clones containing XbaI sites, because of random mutations in the R N A sequence and/or errors during c D N A synthesis (data not shown).
In vitro transcription and infectivity assays
Full-length clones linearized with Asp718 were transcribed with T7 R N A polymerase and used to inoculate local lesion hosts. Typically, 2 to 3 ~tg of R N A transcripts was synthesized per jag of linearized D N A template as estimated from ethidium bromide-stained agarose gels. Several clones were tested, and only SQ104A3 showed local lesions on G. globosa plants. The SQ104A3-derived lesions as well as virus particles isolated from these lesions were indistinguishable from those generated by ? Estimate of infectivity upper limit based on total number of control lesions.
the control PMV RNA. However, the infectivity rate of SQ104A3 transcripts was only 16% that of genomic PMV R N A (1 pg of native PMV R N A normally produces 25 to 50 lesions per G. globosa leaf; see Table  1 ) and uncapped transcripts were less than 2 % as infectious as genomic PMV RNA. Isolated local lesions originating from capped and uncapped SQ104A3 transcripts as well as P M V R N A were used to inoculate other G. gIobosa plants. Lesion counts produced by progeny from transcript-derived lesions were comparable to those obtained with PMV RNA-derived lesions, suggesting that progeny virions had the same level of infectivity as wild-type PMV virions. Plasmid D N A of clone SQ 104A3 was not infectious on G. globosa.
To increase the infectivity of transcripts, a longer poly(A) tail was added at the 3' end of clone SQ104A3. This clone contained only 24 A residues. Clone 71A2 was generated by switching a portion of the 3' non-coding region plus a poly(A) tail of 71 residues from a noninfectious full-length c D N A clone into the 3' end of SQ104A3. A 43 % increase in infectivity of 71A2 over SQ104A3 transcripts was observed (see Table 1 ). Uncapped 71A2 transcripts were less than 5 % as infectious as capped transcripts.
Both SQ104A3 and 71A2 transcripts were infectious on papaya plants as determined by symptomology and dot blot hybridization of total R N A from infected tissue (data not shown). Crude extracts from transcriptinfected papaya plants produced local lesions on G. globosa, indicating the presence of progeny virions.
To determine the effect of 3' non-viral nucleotides on the rate of infectivity, full-length clones were linearized with PvuII, ScaI and NdeI producing non-viral extensions of 192, 1730 and 2434 nucleotides, respectively. As seen in Table 1 , SQ104A3-derived transcripts with nonviral extensions of 192 and 1730 nucleotides displayed infectivity levels of less than 3 % of that of genomic PMV RNA, and transcripts with 2434 nucleotide extensions were only 5 % as infectious as PMV RNA. The rate of infectivity initially decreased with an extension of 192 nucleotides for 71A2 transcripts. Longer extensions of 1730 and 2434 nucleotides, however, showed infectivity rates up to 17% that of genomic PMV RNA; 71A2 transcripts containing 2434 nucleotide extensions appeared to be as infectious as SQ104A3 transcripts with only five extra non-viral nucleotides. Progeny virions isolated from local lesions were similar in length to wildtype PMV virions as observed under the electron microscope. Dot blots of total RNA isolated from papaya plants infected with these extended transcripts produced positive signals with PMV-specific probes whereas plasmid-specific probes were negative (data not shown).
Infectivity of mutant transcripts
Two insertional mutations were produced in the polymerase coding region (176K) by addition of NotI linkers at unique restriction sites. Each of these mutations produced a net addition of two amino acid residues within the polymerase coding region. Both mutants (PL6 and Nco4B) failed to produce any noticeable symptoms on the local lesion host and viral RNA was not detected in dot blots from the systemic host.
The nucleotide sequence of the CP for clone 71A2 was determined by DNA sequencing prior to the construction of CP mutants. Several nucleotide differences resulting in amino acid changes were observed when the sequence was compared to that previously published (Sit et al., 1989) ; isoleucine was changed to threonine at residue 6 and threonine was changed to alanine at position 185. These changes produced an amino acid sequence nearly identical to that reported by Verde et al. (1989) , except for glutamine at amino acid 185 rather than glutamate in clone 71A2 [and in the sequence of Short et al. (1986) ] and the extra glutamine [also found in the sequence of Short et at. (1986) ] between residues 25 and 26 (missing in clone 71A2). The deletion of a cytidine residue was also noted within the non-coding region at position 6547.
Several mutations were introduced into the CP coding region of clone 71A2 (see Fig. 1 ). These included insertions of two amino acid residues (CPN6 and CPSN7), premature termination of the CP (CPHN2 and CPX7), a frameshift mutation leading to an extension of the CP coding region (11CP4) and deletions of one and 158 amino acids (3CP1 and ACP9, respectively). The replication of CP mutants was not detectable on local lesion hosts except for mutant 3CP1 which produced lesions smaller than those of either 71A2 transcripts or PMV RNA. Lesions derived from 3CP1 transcripts took 14 days to appear as opposed to 4 to 5 days for 71A2 transcripts or PMV RNA. The infectivity rate of 3CP1 transcripts was about 49% that of 71A2 transcripts. Mutant 3CP1 contained a single amino acid deletion (alanine) at position 178 (native CP contains 215 amino acids) which presumably destabilized the viral capsid because viral particles were not observed in crude lesion extracts using the electron microscope. Crude extracts from 3CP1 lesions failed to produce local lesions on other G. globosa plants. Dot blots of total RNA from papaya plants infected with any of the various CP mutant transcripts failed to detect any viral RNA (data not shown).
Discussion
Initially, genomic length clones of PMV were constructed from subclones utilized in the sequencing of the genome. This approach produced clones which were not infectious despite the success of others employing a similar cloning strategy for e.g. CPMV (Vos et al., 1988) , TVMV (Domier et at., 1989) and turnip crinkle virus (TCV; Heaton et al., 1989) . It was thought that one or several of the PMV subclones used contained alterations to the coding sequences despite sequencing of the cloned junctions after each subcloning step. We produced fulllength cDNA copies of the PMV RNA genome in one cloning step with 5' and 3' virus-specific primers. We obtained a higher percentage of full-length ds cDNA by using Sequenase Version 2.0 (with its high processivity) than using Klenow enzyme (see Fig. 2 ) for second strand synthesis.
The method of Schmid et al. (1987) used for cloning cDNA fragments into a plasmid vector proved to be of limited use for the 6"6 kb genome. In our hands, GCtailing with terminal transferase produced the only fulllength genomic cDNA clones in plasmid pUC18. By incorporating the T7 promoter within the 5' primer sequence, we were able to clone the cDNA insert in a plasmid lacking a T7 promoter and avoided the need to modify the transcription start site and 5' end of the viral sequence by site-directed mutagenesis.
The infectivity rate on G. globosa of capped SQ104A3 RNA transcripts containing 24 A residues at the 3' end was only 16 % that of wild-type genomic PMV RNA. Uncapped transcripts were infectious but at extremely low levels (< 2 % as infectious as genomic RNA). This dramatic decrease in infectivity of uncapped transcripts was also noticed for other viral transcripts (Janda et al., 1987; Meshi et al., 1986; Heaton et al., 1989; Beck et al., 1990) . For several viruses, uncapped transcripts were not infectious (Dawson et al., 1986; Riechmann et al., 1990) . In contrast, uncapped transcripts were more infectious than capped ones for tomato bushy stunt virus (Hearne et al., 1990 ).
The 16 % infectivity rate of SQ104A3 transcripts was higher than the 0.2 % infectivity rate of PVX transcripts obtained by Hemenway et al. (1990) . The PVX transcripts contained 16 A residues at the 3' end and those of WC1MV transcripts contained 74 A residues generating infectivity rates close to those of genomic WC1MV RNA (Beck et al., 1990) . We reasoned that the addition of a longer poly(A) tail on PMV transcripts might increase their infectivity rate to near genomic RNA levels since viral RNA normally contains 50 to 125 A residues at the 3' terminus (AbouHaidar, 1988) . Likewise, the infectivity of poliovirus transcripts was increased to wild-type levels by the addition of a longer poly(A) tail (Sarnow, 1989) . The infectivity of 71A2 transcripts (containing 71 A residues) was increased to 23 % of PMV RNA, a modest improvement of 43 % over SQ104A3 transcripts (containing 24 A residues). Guilford et at. (1991) noticed only a slight decrease (about 16 %) in the infectivity of WC1MV transcripts when the poly(A) tail length was shortened to 27 A residues. Progeny virions generated by capped as well as uncapped transcripts appear to be as infectious as native virions. This indicates that our lower than genomic infectivity rates might be due to poor capping efficiencies rather than an alteration to the RNA sequence.
The effect on infectivity of long 3' non-viral extensions varied with the length of the poly(A) tail. SQ104A3 transcripts (with 24 A residues) containing non-viral extensions of up to 2434 nucleotides demonstrated highly reduced levels of infectivity as compared to the usual five nucleotide extensions. The 71A2 transcripts, which contain 71 A residues, showed infectivities ranging from 8 to 17% of the figure for genomic RNA. 71A2 transcripts containing 2434 non-viral nucleotide extensions appeared to be as infectious as any SQ104A3 transcript. The overall decrease in infectivity levels with 3' non-viral extensions are in agreement with those reported for CPMV (Eggen et al., 1989) , TMV strain L and WC1MV (Beck et al., 1990 ). However, the infectivity level of 71A2 transcripts containing 2434 extra nucleotides was unexpected. This effect might be due to protection from exonuclease digestion by the longer extensions, or the secondary structure of the longer plasmid-derived sequences may produce less steric hindrance to polymerase recognition than the shorter non-viral extensions.
Several mutations were introduced into the polymerase and CP genes of 71A2. These mutations allowed testing for functional domains/regions of these proteins required for replication and host symptom response. Insertional mutations of two amino acid residues within the non-homologous and C-terminal conserved regions of the polymerase gene (mutants PL6 and Nco4B, respectively) abolished infectivity on G. globosa (local host) and C. papaya (systemic host). The variability (in terms of size and amino acid sequence) of the central non-homologous region of potexviral ORF 1 products (putative polymerase) made this region an obvious choice for mutagenesis since many potexviruses can infect G. globosa (Short & Davies, 1987 ) despite these differences in their viral polymerases. The lack of infectivity of mutant PL6 indicates that this central non-homologous region is essential for replication and may interact with host components to form the functional replicase complex. The addition of two amino acids in this region may then alter the secondary structure of the polypeptide so that it no longer interacts with the necessary host components. The mutation of clone Nco4B involved insertion of two amino acids between the NTPase/ helicase motif and the conserved GDD polymerase motif. This mutation might have altered the functions of the two regions of the polymerase causing a decrease in, or loss of, polymerase activity. The addition of two amino acid residues within the polymerase gene might have been too severe because most two-amino acid insertions within the BMV l a protein (a component of the viral polymerase) were lethal, especially near the NTPase/helicase motif (Kroner et al., 1990) . However, single amino acid insertions near the conserved GDD motif of the BMV 2a protein (a component of the viral replicase) produced infectious transcripts (Kroner et al., 1989) , as did similar insertions within the 183K polymerase gene of TMV although at a reduced rate and with the production of smaller lesions . Both BMV and TMV, as well as PMV, belong to the Sindbis-like supergroup of plant viruses which have related non-structural proteins involved in replication (Goldbach, 1986) .
CP mutations involving insertion of two amino acid residues and premature termination codons were located towards the N and C termini (see Fig. 1 ). Deletion of most of the CP coding region, as well as a frameshift mutation at the C terminus of the CP, were also produced. These mutations were designed to test the requirement for intact CP during the infectivity cycle of PMV. CP deletion mutants of beet necrotic yellow vein virus (Quillet et al., 1989) , barley stripe mosaic virus (BSMV; Petty & Jackson, 1990) , TCV (Hacker et al., 1992) , TMV (Takamatsu et al., 1987; Dawson et al., 1988) and tobacco rattle virus (TRV) RNA2 (Angenent et al., 1989) were still infectious despite the lack of a functional CP. RNA1 of the bipartite tobravirus TRV can replicate in the absence of RNA2 which encodes the CP gene (Harrison & Robinson, 1986; Hamilton & Baulcombe, 1989) . The absence of any symptoms on the local lesion host G. gtobosa inoculated with CP mutant transcripts indicated that either the viral transcripts were biologically inactive or that the CP mutants produced asymptomatic infections. The systemic host (C. papaya) also failed to support detectable replication and systemic movement of CP mutant transcripts. Several CP deletion mutants of BSMV were non-infectious on the local lesion host Chenopodium amaranticolor but replicated well in the systemic host, barley (Petty & Jackson, 1990) . Similarly, CP[-] mutants of TMV produced local lesions on Nicotiana tabacum L. cultivar Xanthi-nc whereas infection of N. sylvestris (local lesion host) was asymptomatic (Culver & Dawson, 1989) .
The replication of mutant 3CP1, which lacked an alanine residue towards the C terminus of the CP, indicates that the complete PMV CP is not necessarily required for infectivity. The inability to detect virus particles from crude lesion extracts and to passage the mutant lesions from crude extracts implies that this mutant exists as a naked RNA species. It is unclear whether the mutated CP has a defect in CP-RNA interactions or in protein-protein interactions during the assembly process. According to the model proposed for the PVX CP by Baratova et al. (1992) the deleted amino acid is found within an area of the CP that does not contain a-helical or fl-structural regions involved in the folding of the CP.
The production of smaller lesions by mutant 3CP1 (compared to lesions produced by genomic RNA) was also observed with CP mutants of TCV (Hacker et al., 1992) . The altered interaction of the mutated CP with host components may be responsible for the change in lesion size since the CP of PVX has been implicated in host symptom responses. Hybrid transcripts of PVX strains have shown that the ability to overcome host resistance resides within the CP amino acid sequence of the different strains (Kavanagh et al., 1992) . This phenotype may also be a consequence of poor replication since polymerase mutants of TMV also produced a smaller lesion phenotype .
The proximity of the three-nucleotide deletion of mutant 3CP1 towards the 3' terminus (about 220 nucleotides from the 3' end) might have affected replication by altering the secondary structure of the RNA for polymerase recognition. Intact CP may also be required for some other unknown function during replication which was partially disrupted in mutant 3CP1. The delay in lesion formation would not appear to be a result of deficient cell to cell spread since the 'triple gene block' proteins implicated in cell-to-cell movement were unaltered in CP mutants. Further work on assembly of viral RNA with this mutated CP will determine whether protein-protein or protein-RNA interactions have been affected by this mutation.
